RAD Increases Ownership in Radiopharm Ventures to 75%

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet

Major Market Shift As Week Ends Strong!

In this StockCharts TV video, Mary Ellen reviews the broader market’s health while highlighting big shifts into newer areas, including banks, retail, and